Q3 2022 Holdings
Filed 2022-11-07 | 60 holdings | $18.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2022-11-28) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $9.1K | 85,240 | 0.0% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $51.7K | 727,785 | 0.3% |
| Alphatec Holdings Inc(ATEC) | COM | 02081G201 | $87.0K | 10,000 | 0.5% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $252.0K | 20,000 | 1.4% |
| Cullinan Management Inc(CGEM) | COM | 230031106 | $322.0K | 25,114 | 1.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $667.0K | 15,000 | 3.7% |
| Cytokinetics Inc(CYTK) | COM | 23282W605 | $1.2M | 25,000 | 6.6% |
| Corcept Therapeutics Inc(CORT) | COM | 218352102 | $1.3M | 50,000 | 7.0% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $4.1M | 249,400 | 22.4% |
| Aziyo Biologics Inc(ELUT) | COM | 05479K106 | $10.2M | 1,418,123 | 56.0% |